Methods of treating non-painful bladder disorders using Alpha2Delta subunit calcium channel modulators

Details for Australian Patent Application No. 2010200722 (hide)

Owner Dynogen Pharmaceuticals, Inc.

Inventors Thor, Karl Bruce; Burgard, Edward C.; Fraser, Matthew Oliver

Agent Pizzeys

Pub. Number AU-A-2010200722

Parent 2003301184

Filing date 26 February 2010

Wipo publication date 18 March 2010

International Classifications

A61K 31/195 (2006.01)

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/197 (2006.01)

Event Publications

11 March 2010 Complete Application Filed

18 March 2010 Application Open to Public Inspection

  Published as AU-A-2010200722

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200723-A method of placing visible advertising

2010200721-Infusion fluid heat exchanger and cartridge